Issued Patents All Time
Showing 51–75 of 96 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9783507 | Neprilysin inhibitors | Anne-Marie Beausoliel, Adam D. Hughes, Daniel D. Long, Donna A. A. Wilton | 2017-10-10 |
| 9771337 | Neprilysin inhibitors | Roland Gendron, Adam D. Hughes, Jane Schmidt | 2017-09-26 |
| 9771350 | Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity | Adam D. Hughes, Daniel H. Byun, Yan Chen, John R. Jacobsen, Eric L. Stangeland +2 more | 2017-09-26 |
| 9725448 | Neprilysin inhibitors | Roland Gendron, Adam D. Hughes, Cameron Smith | 2017-08-08 |
| 9725470 | Substituted naphthyridines as JAK kinase inhibitors | Ryan Hudson, Jennifer Kozak, Paul R. Fatheree, Dante D. Podesto, Gary E. L. Brandt +1 more | 2017-08-08 |
| 9724359 | Neprilysin inhibitors | Roland Gendron, Adam D. Hughes | 2017-08-08 |
| 9688616 | Neprilysin inhibitors | Erik Fenster, Adam D. Hughes | 2017-06-27 |
| 9688692 | Neprilysin inhibitors | Roland Gendron, Adam D. Hughes | 2017-06-27 |
| 9682052 | Neprilysin inhibitors | Adam D. Hughes, Erik Fenster, Roland Gendron, Edmund J. Moran | 2017-06-20 |
| 9683002 | Neprilysin inhibitors | Adam D. Hughes | 2017-06-20 |
| 9682957 | Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity | Adam D. Hughes, Daniel H. Byun, Yan Chen, John R. Jacobsen, Eric L. Stangeland +2 more | 2017-06-20 |
| 9670143 | (2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxmethyl-2-methylpentanoic acid | Adam D. Hughes, Erik Fenster, Anne-Marie Beausoleil, Venkat R. Thalladi, Jerry Nzerem +1 more | 2017-06-06 |
| 9670186 | Neprilysin inhibitors | Adam D. Hughes | 2017-06-06 |
| 9593110 | Neprilysin inhibitors | Anne-Marie Beausoliel, Adam D. Hughes, Daniel D. Long, Donna A. A. Wilton | 2017-03-14 |
| 9585882 | Neprilysin inhibitors | Anne-Marie Beausoliel, Adam D. Hughes, Daniel D. Long, Donna A. A. Wilton | 2017-03-07 |
| 9572802 | Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity | Adam D. Hughes, Daniel H. Byun, Yan Chen, John R. Jacobsen, Eric L. Stangeland +2 more | 2017-02-21 |
| 9555041 | Neprilysin inhibitors | Cameron Smith, Roland Gendron, Ryan Hudson, Adam D. Hughes | 2017-01-31 |
| 9533962 | (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid | Adam D. Hughes, Anne-Marie Beausoleil, Erik Fenster, Venkat R. Thalladi, Miroslav Rapta | 2017-01-03 |
| 9499487 | Neprilysin inhibitors | Roland Gendron, Adam D. Hughes, Jane Schmidt | 2016-11-22 |
| 9487514 | Neprilysin inhibitors | Roland Gendron, Adam D. Hughes, Cameron Smith | 2016-11-08 |
| 9433598 | (2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid | Adam D. Hughes, Erik Fenster, Anne-Marie Beausoleil, Venkat R. Thalladi, Jerry Nzerem +1 more | 2016-09-06 |
| 9428457 | Neprilysin inhibitors | Erik Fenster, Adam D. Hughes | 2016-08-30 |
| 9388145 | Neprilysin inhibitors | Roland Gendron, Adam D. Hughes | 2016-07-12 |
| 9334245 | Neprilysin inhibitors | Roland Gendron, Adam D. Hughes | 2016-05-10 |
| 9150500 | Neprilysin inhibitors | Adam D. Hughes, Erik Fenster, Roland Gendron, Edmund J. Moran | 2015-10-06 |